Status:
UNKNOWN
COVID-19 and Tissue Damage in Vital Organs
Lead Sponsor:
Dokuz Eylul University
Conditions:
Covid19
Postmortem Changes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study will be conducted in Dokuz Eylül University Hospital, COVID-19 (Coronavirus Disease 2019) intensive care unit. Three primary conditions will be sought for participants: 1. Cases whose treat...
Detailed Description
The cases whose treatment resulted in death at Dokuz Eylül University Research and Application Hospital Anesthesiology Intensive Care Unit and whose COVID-19 diagnosis was confirmed by the RT-PCR (rea...
Eligibility Criteria
Inclusion
- Cases 18 years and older than 18 years.
- Cases diagnosed with COVID-19 confirmed by PCR test.
- Cases whose treatment resulted in death.
- Cases that was allowed the participation in the study by signing the informed consent form by their first degree relatives.
Exclusion
- Cases less than 18 years old.
- Cases for which the diagnosis of COVID-19 could not be confirmed.
- Cases for which informed consent could not be obtained.
- Cases whose treatment continues or results in healing.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04678687
Start Date
January 1 2021
End Date
January 1 2022
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dokuz Eylul University
Izmir, Balçova, Turkey (Türkiye), 35330